Skip to main content

Marpai, Inc.

corporate_fare Company Profile

Marpai, Inc.

MRAI·OTC·Industrial Applications And Services·CIK 0001844392

Our Business is a technology platform company that operates subsidiaries providing Third Party Administrator (TPA), Pharmacy Benefit Management (PBM), and value-oriented health plan services. We serve self-insured employers in the U.S. who directly pay for employee health benefits. Our Clients are these self-insured employers, most of whom are small and medium-sized companies as well as local government entities. We administer healthcare claims for these Clients and their employees and family members, referred to as Members. We also interact with healthcare Providers, including doctors, doctor groups, hospitals, clinics, and other entities offering healthcare services or products. We aim to provide affordable, intelligent healthcare programs and administrative services to these self-insured employers. In 2024, U.S. private health insurance spending reached $1.6 trillion, according to the Centers for Medicare and Medicaid Services (CMS). Employers, especially small and mid-sized enterprises (SME), are increasingly self-insuring to gain control over healthcare spending and capture margins. Health plans and employers are seeking to control costs through programs such as payment integrity, care management, care navigation, reference-based pricing, claims repricing, centers of excellence, specialty/narrow networks, and subrogation. As of 2025, employee benefits are a significant and growing part of total employee compensation, increasing faster than wages recently.

Marpai, Inc. (OTC:MRAI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 11 items for MRAI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-13, rated 8/10. Across its 11 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for MRAI spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Marpai Q2 Loss Widens, Cash Drops to $138K; Going Concern Warning Reiterated
  • Marpai Secures $12M via Convertible Preferred Stock at $1.00 Conversion Price, Led by Mitchell Companies
  • $12M Private Placement Led by Mitchell Companies Bolsters Marpai's Cash
  • Marpai Restructures AXA Debt, Slashes Near-Term Payments by $26.4M Through 2027
  • Marpai Reports 18% Revenue Decline in Q1, Explores Strategic Alternatives Amid Financial Distress

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$18.1M
Net Income
-$16.56M
Diluted EPS
-$0.95
Op. Cash Flow
-$7.45M
Operating Income
-$13.55M
Cash & Equivalents
$133K
Total Debt
$30.4M
Debt / Equity
-0.93×
Net Margin
-91.5%
Shares Outstanding
24.04M sh
Source: 10-K · filed 2026-03-25 · accession 0001213900-26-034129

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 66,965 shares in MRAI as of the September 15, 2026 settlement, a 3.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 43.8% of MRAI volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)66,965 shares as of September 15, 2026
Change vs prior period▲ 3.8%
Days to cover1.00 at avg daily volume of 304,103
Daily short volume (FINRA facilities)43.8% of 4,455 shares on October 2, 2026
5-day average short volume57.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →
$3.43 +0.13% today
52-week range · as of 2026-08-13 $0.215 – $3.43
Market cap
$92.03M
Volume
4.5K (0.1× avg)
3-mo avg 74.7K
Live data · 2026-10-05 02:05 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MRAI - Latest Insights

MRAI
Aug 13, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.19
Real-time Price: $3.43 info
Change: +$1.24 (+57%) info
Market Cap: $92.026M info
MRAI
Jul 31, 2026, 5:29 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.23
Real-time Price: $3.43 info
Change: +$1.20 (+54%) info
Market Cap: $92.026M info
MRAI
Jul 29, 2026, 6:06 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.89
Real-time Price: $3.43 info
Change: +$1.54 (+81%) info
Market Cap: $92.026M info
MRAI
Jul 20, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.22
Real-time Price: $3.43 info
Change: +$1.21 (+55%) info
Market Cap: $92.026M info
MRAI
May 15, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.2903
Real-time Price: $3.43 info
Change: +$3.14 (+1,082%) info
Market Cap: $92.026M info
MRAI
May 15, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.2903
Real-time Price: $3.43 info
Change: +$3.14 (+1,082%) info
Market Cap: $92.026M info
MRAI
May 01, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.260
Real-time Price: $3.43 info
Change: +$3.17 (+1,219%) info
Market Cap: $92.026M info
MRAI
Mar 25, 2026, 4:55 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.451
Real-time Price: $3.43 info
Change: +$2.98 (+661%) info
Market Cap: $92.026M info
MRAI
Mar 25, 2026, 4:44 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.451
Real-time Price: $3.43 info
Change: +$2.98 (+661%) info
Market Cap: $92.026M info
MRAI
Mar 11, 2026, 8:28 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4964
Real-time Price: $3.43 info
Change: +$2.93 (+591%) info
Market Cap: $92.026M info
MRAI
Feb 13, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.400
Real-time Price: $3.43 info
Change: +$3.03 (+758%) info
Market Cap: $92.026M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets